This week marked the First U.S. case day for the HORIZON 360 paroxysmal AF study—and proud to contribute to some of the first U.S. enrollments. Grateful to St. Bernards Healthcare, Medtronic Cardiac and Vascular , and Dr. Vivek Reddy for their collaboration and insights as we work to advance PFA platforms and atrial fibrillation care. Proud to serve as PI at @ARGJonesboro in Jonesboro, AR, using the Sphere 360 PFA system with #Affera mapping—with an intuitive workflow, a streamlined map-and-ablate strategy, and zero fluoroscopy. @khaldountarakji@Medtronic
EPs: Ready to streamline your AF ablation workflow?
Join Drs. Mountantonakis & Sood for a live webinar on the zero exchange workflow using Medtronic PFA technology.
🗓️ June 26 | 🕖 7–7:30 PM ET
Register: https://t.co/3Hsq26hEO1
#PFA#AFib#CardiacAblation#Epeeps#EPInsightsLive
Medtronic has reached an incredible milestone of 60,000+ PFA experiences globally! Discover more about the next era of EP. #PulseSelect#Sphere9#Epeeps#PFA#Affera
Learn more: https://t.co/X3PFCwNw8P
See risk info: https://t.co/qmkkT1qvMZ & https://t.co/3nLidkpNNP
Medtronic has reached an incredible milestone of 60,000+ PFA experiences globally! Discover more about the next era of EP. #PulseSelect#Sphere9#Epeeps#PFA#Affera
Learn more: https://t.co/olskb0BEIh
See risk info: https://t.co/HGvBZ662dM & https://t.co/soXOLb9VNT
Congratulations to @SunriseMedical for completing their first case with the Affera™ Mapping and Ablation System and Sphere-9™ Catheter! #afferamapping#epeeps#pfa
Learn more: https://t.co/Bl3DaBjZWa
See risk info: https://t.co/Bl3DaBjZWa
It’s now full circle: Sphere 360™ 12-month outcomes now published in Heart Rhythm Journal.
The Sphere-360 catheter is investigational and not
for sale in any geography.
Read the full manuscript: https://t.co/fMsWiBIxKa
BREAKING: Presented at #HRS2025 and published in @hrs_journal, one-year results from the High Impact Science Session highlight the safety and effectiveness of the Sphere-360 pulsed field ablation catheter for treating paroxysmal AFib. #HRStv host @DanielAlyeshmer is joined by @VivekReddyMD to discuss the first-in-human data. See the full interview here #EPeeps ➡️ https://t.co/qwL9wbvTQl
Don’t miss the oral presentation on one-year outcomes of a conformable single-shot pulsed field ablation catheter for the treatment of paroxysmal atrial fibrillation at #HRS2025 Saturday, April 26 at 3:42 p.m. PT! #epeeps#pfa
Learn more: https://t.co/GrumfZY8ul
Experience lesion contiguity with Medtronic PFA — create consistent electric fields regardless of catheter position. #epeeps
Risks may include serious complications and injuries to cardiac and other body structures.
See evidence and risk information: https://t.co/yfZFbhsMyK
A specialized medical team at the Pediatric Cardiac Surgery Unit at King Abdulaziz University Hospital has successfully performed the first procedure to treat atrial fibrillation using Pulse Field Ablation (PFA) catheter technology by Medtronic, one of the latest innovations in the field of cardiology and cardiac surgery.
This achievement highlights the university hospital’s medical excellence in adopting cutting-edge treatment innovations, aiming to provide advanced healthcare to patients in accordance with the highest international standards.
#KingAbdulazizUniversity #MedicalAchievement #CardiacCatheterization
Thank you to everyone who attended the 2025 Cardiac Ablation Summit! A special thanks to our incredible faculty & course directors, Dr. Devi Nair & Dr. Suneet Mittal, for their contributions & discussions! We hope to see you all again next year!
#CardiacAblationSummit#Epeeps
As Northwestern @NMCardioVasc becomes the 1st EP program in IL to perform ablation with the MDT Sphere-9 PFA catheter using the Affera mapping system, our team continues to lead the way in the region with early adoption of revolutionary PFA systems. An amazing time to for EP.
Congratulations to Dr. Oussama Wazni, Dr. Pasquale Santangeli, Dr. Koji Higuchi and the entire Electrophysiology team at the Cleveland Clinic for completing their first week of cases with the Affera Mapping and Ablation System and the Sphere-9 catheter!
What's important about this publication is not just that contact matters, but that the overall level of hemolysis is very low with PulseSelect. De Smet et al in Europace published that hemolysis is same between Farapulse and Varipulse - about 2X more than PS. Details matter.
Congratulations to Dr. Jeffrey Winterfield and staff at the Medical University of South Carolina for completing first cases with the Affera™ mapping and ablation system and Sphere-9™ catheter! Learn more: https://t.co/PPFbdKrbCH See risk info: https://t.co/EQmojYHMBS
Now FDA approved! The Affera™ Mapping and Ablation System with first-of-its-kind, wide area focal Sphere-9™ Catheter featuring all-in-one: HD mapping & dual-energy (RF/PF) ablation to treat AF patients. Learn more: https://t.co/RmcK6gimcs See risk info: https://t.co/06g17YUR0H
A PFA durability study using PulseSelect™ PFA System demonstrates durable lesion formation without compromising safety. Learn more about the data presented by @Devinair#EPeeps#PFA#PulseSelect
See Risk/Benefit info: https://t.co/C6i7VuwqvU
Learn more: https://t.co/9LCXePs6j8
The new FlexCath Contour™ steerable sheath is the first and only bi-directional sheath designed for pulsed field ablation procedures. Learn more: https://t.co/L2BXCrjNCs See risk/benefit info: https://t.co/fqrGKc0xES